Table 1.
Baseline Characteristics.
| Clinical Characteristics | |
| Age, Yrs § | 79.4 (50–88) |
| Male | 10 (41.6%) |
| STS Score † | 3.9 ± 2.37 |
| Euroscore II † | 5 ± 4.05 |
| NYHA II NYHA III NYHA IV |
1 (4.1%) 22 (91.6%) 1 (4.1%) |
| GFR § | 59 (5–132) |
| Dialysis | 1 (4.1%) |
| Hypertension | 18 (75%) |
| Diabetes | 4 (16.6%) |
| Dislipemia | 11 (45.8%) |
| Chronic pulmonary Disease | 5 (20.8%) |
| End Stage Liver Failure | 1 (4.1%) |
| Prior CVA | 3 (12.5%) |
| Atrial fibrillation | 1 (4.1%) |
| Coronary artery disease | 6 (25%) |
| Prior PM | 5 (20.8%) |
| Prior MI | 0 (0.0%) |
| Prior PCI | 1 (4.1%) |
| Prior CABG | 1 (4.1%) |
| Prior Valve Surgery* | 2 (8.3%) |
| Transthoracic Echocardiography | |
| Left Ventricle Ejection Fraction, % § | 48.5 (30–65) |
| Left Ventricle End Diastolic Diameter, mm§ | 60 (41–83) |
| Mean Aortic Gradient, mmHg § | 13.8 (3–25) |
| Aortic Regurgitation 3+/4 4+/4 |
8 (33.3%) 16 (66.6%) |
| Mitral Regurgitation none 1+/4 2+/4 3–4+/4 |
3 (12.5%) 2 (8.3%) 6 (25%) 13 (54.1) |
| Pulmonary Hypertension | 7 (29.1%) |
| Ascending Aorta Diameter, mm § | 33.6 (22–45.2) |
| Multidetector Computed Tomography | |
| Annulus Area, mm2 § | 440 (299–510) |
| Annulus Perimeter, mm § | 77.1 (62.6–81.3) |
| Perimeter Derived Diameter, mm § | 23.4 (20–26.3) |
| Minimum Diameter, mm § | 20 (17.3–24.9) |
| Maximum Diameter, mm § | 26.1 (22.5–29.8) |
| Aortic valve calcifications Absent Mild Moderate Severe |
3 (12.5%) 8 (33.3%) 12 (50%) 1 (4.1%) |
| Ascending Aorta Diameter, mm § | 34.5 (22–45.2) |
| Bicuspid Valve | 1 (4.1%) |
STS = Society of Thoracic Surgeons; NYHA = New York Heart Association; CVA = cerebral vascular accident; PM = pacemaker; MI = myocardial infarction; CABG = coronary artery bypass graft; PCI = percutaneous coronary therapy. The GFR was calculated with the CKD-EPI formula.
†
Data are presented as mean ± standard deviation. § Data are expressed as median (min–max).
*
One patient underwent mitral valve surgery, the other pulmonary homograft surgery